News search
 Research 30 Aug 2024 Two studies carried out at the CNIC provide key information about a newly identified cardiovascular risk factor, clonal hematopoiesis, and its treatment with the ancient medication colchicine |
 About the CNIC 23 Feb 2022 Researchers from the CNIC and Columbia University (USA) review the role of acquired mutations and clonal hematopoiesis in cardiovascular disease |
 Research 5 Apr 2021 The study, carried out at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and the Hospital Universitario Virgen de Arrixaca in Murcia, establishes clonal hematopoiesis as a new cardiovascular risk factor and an important link between aging and cardiovascular disease |
 About the CNIC 23 Dec 2020 The project will investigate the role of clonal hematopoiesis—the formation of mutated hematopoietic stem-cell clones promoted by anti-cancer therapies—in the development of atherosclerosis and associated cardiovascular disease |
 About the CNIC 4 Jul 2018 ‘Clonal hematopoiesis and atherosclerosis’ will receive a total funding of $6,000,000, of which $712,500 correspond to the CNIC |
